Physician Appointed Clinical Professor at University of Nevada School of Medicine

Spread the Word
Listed Under

* Radiation Oncology
* Las Vegas Cancer Treatment

* Health
* Medical

* Las Vegas - Nevada - US

LAS VEGAS - July 16, 2014 - PRLog -- 21st Century Oncology of Las Vegas is pleased to announce that the University of Nevada School of Medicine has appointed one of our physicians, Brian Lawenda, M.D., Board Certified Radiation Oncologist, to be a Clinical Professor in the Department of Internal Medicine.

Dr. Lawenda has been instrumental in bringing High Dose Rate Skin Brachytherapy to Southern Nevada. He has received numerous awards, including the “Top Doctor” award in radiation oncology by U.S. News and World Report, as well as the “Top Doctor” award in both Las Vegas Life Magazine and Seven Magazine.

“The University of Nevada School of Medicine has an exceptional reputation in our community and it’s an honor to be appointed as a Clinical Professor to be part of that,” said Dr. Lawenda. “I’m looking forward to this opportunity to educate the next generation of physicians.”

Dr. Lawenda is a Harvard-trained radiation oncologist and Stanford/UCLA-trained medical acupuncturist. He earned his medical degree from Temple University School of Medicine in Philadelphia, Pa. and went on to complete his internship with the U.S. Navy at the Naval Medical Center in San Diego, Calif. He is also the National Director of the Integrative Oncology and Cancer Survivorship Program for 21st Century Oncology.

For more information about our services, visit or call 702-894-5100.

About 21st Century Oncology:

21st Century Oncology is the largest global, physician led provider of Integrated Cancer Care services. The company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. The company operates 185 treatment centers, including 150 centers located in 16 states. The company also operates 35 centers located in six countries in Latin America. The company holds market-leading positions in most of its domestic local markets and abroad.

Melissa Rogovin
Email:*** Email Verified
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
21st Century Oncology News
Daily News
Weekly News

Like PRLog?
Click to Share